Cyclin-Dependent Kinase 12, Immunity, and Prostate Cancer

N Engl J Med. 2018 Sep 13;379(11):1087-1089. doi: 10.1056/NEJMcibr1808772.

Author

Emmanuel S Antonarakis¹

Affiliation

¹ From the Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center, Baltimore.

PMID: 30207914
DOI: 10.1056/NEJMcibr1808772

No abstract available

MeSH terms

Cyclin-Dependent Kinases / genetics*
Genomic Instability
Humans
Loss of Function Mutation*
Male
Programmed Cell Death 1 Receptor / antagonists & inhibitors
Prostatic Neoplasms, Castration-Resistant / drug therapy
Prostatic Neoplasms, Castration-Resistant / genetics*
Prostatic Neoplasms, Castration-Resistant / immunology

Substances

Programmed Cell Death 1 Receptor
CDK12 protein, human
Cyclin-Dependent Kinases